JAGSNPHARM logo

Jagsonpal Pharmaceuticals

JAGSNPHARM·NSE·
236.25 -3.38 (-1.41%)
Market Cap1558.24 Cr
PE Ratio36.74
Volume27,105
Day High - Low239.55 - 236.00
52W High-Low264.50 - 155.00
DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
15.58%
Strong
P/E
36.74x
Expensive
Debt / Equity
0.03
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day236.00
239.55
52W155.00
264.50
DocStoX take

Supported by risk (7.9) and growth (7.6), but held back by valuation (1.3). Risk looks strong at 7.9, but that is offset by valuation at 1.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Solid
ROE 15.6%
Valuation
Expensive
P/E 36.7×
Growth
Strong
Revenue +8.8% 5Y CAGR
Risk
Low risk
D/E 0.03
Momentum
Strong
74% of 52-week range

At a glance

Market Cap
₹1,558 Cr
52W High / Low
₹265 / ₹155
Dividend Yield
1.69%
Promoter Holding
69.05%
EPS (TTM)
₹6.43
Book Value
₹41.27

Key highlights

  • Low leverage — D/E 0.03
  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 23%
  • Valuation is weak (1.3/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

JAGSONPAL PHARMACEUTICALS peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.